Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment.
about
Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human geneticsMicroRNAs: Novel immunotherapeutic targets in colorectal carcinomaTight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancerApoptosis, Necrosis, and Necroptosis in the Gut and Intestinal HomeostasisClinical use and mechanisms of infliximab treatment on inflammatory bowel disease: a recent updateMolecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseasesAnti-diarrheal mechanism of the traditional remedy Uzara via reduction of active chloride secretionMarine hydroquinone zonarol prevents inflammation and apoptosis in dextran sulfate sodium-induced mice ulcerative colitisAltered distribution of tight junction proteins after intestinal ischaemia/reperfusion injury in ratsIncrease in the tight junction protein claudin-1 in intestinal inflammationAlteration in intestine tight junction protein phosphorylation and apoptosis is associated with increase in IL-18 levels following alcohol intoxication and burn injuryInflammatory bowel diseaseChanges in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease.CARD15/NOD2 is required for Peyer's patches homeostasis in mice.Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: a novel model for studying the pathomechanisms of inflammatory bowel disease cytokines.Enteral versus parenteral nutrition: effect on intestinal barrier function.Norovirus non-structural protein p20 leads to impaired restitution of epithelial defects by inhibition of actin cytoskeleton remodelling.Regulation of intestinal barrier function by signal transducer and activator of transcription 5b.Cell death and inflammatory bowel diseases: apoptosis, necrosis, and autophagy in the intestinal epithelium.Inflammatory bowel disease in pediatric and adolescent patients: a biomolecular and histopathological reviewEpithelial barrier: an interface for the cross-communication between gut flora and immune system.Exposure to lipopolysaccharide and/or unconjugated bilirubin impair the integrity and function of brain microvascular endothelial cellsEnterocyte cytoskeleton changes are crucial for enhanced translocation of nonpathogenic Escherichia coli across metabolically stressed gut epithelia.Intestinal epithelial cells as producers but not targets of chronic TNF suffice to cause murine Crohn-like pathologyPUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice.Erythropoietin protects epithelial cells from excessive autophagy and apoptosis in experimental neonatal necrotizing enterocolitisIntestinal-specific TNFα overexpression induces Crohn's-like ileitis in miceMiR-29a promotes intestinal epithelial apoptosis in ulcerative colitis by down-regulating Mcl-1Ablation of tumor necrosis factor is associated with decreased inflammation and alterations of the microbiota in a mouse model of inflammatory bowel disease.IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunctionEvidence that tight junctions are disrupted due to intimate bacterial contact and not inflammation during attaching and effacing pathogen infection in vivo.Moxibustion combined with acupuncture increases tight junction protein expression in Crohn's disease patients.Monocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBD.AMP-18 Targets p21 to Maintain Epithelial Homeostasis.Epithelial apoptosis in mechanistically distinct methods of injury in the murine small intestineUpdate on biologic pathways in inflammatory bowel disease and their therapeutic relevance.Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's diseasep53 mediates TNF-induced epithelial cell apoptosis in IBD.Slipping the barrier: how variants in CARD15 could alter permeability of the intestinal wall and population healthTNFalpha blockade in human diseases: mechanisms and future directions.
P2860
Q21131205-32CAB178-20F7-485A-A313-61C4B5941206Q26747339-9019D57D-79E1-4EB5-8970-C513454A3C5AQ26752750-859E70D2-3890-4C43-9ECA-FDF954AB44BEQ26781665-703F4519-C701-4085-94B3-CD16F3B37E37Q26994776-3C7AB30F-25E1-498A-B7A9-0FCC8346C208Q28067245-55B11994-2C3F-4F87-932B-CEE7CAC9B431Q28477555-7D1B2C75-0D49-4270-AC6B-5F445715B03CQ28545062-BEF22DD9-56B3-4E57-945E-461E4A3E8852Q28568821-60C8999D-46A2-4B19-8F0C-6BB75C6725ADQ28577922-23190D4C-D0A9-475C-A82A-3C7B2704150AQ28582407-48100FEF-0778-4B26-91A7-5F5E1CC09BD9Q29615500-E0A26748-EE12-489C-85E9-C4F010FB7451Q33249005-32FCD193-ED15-4664-B6CB-58C5CE5F9630Q33287474-111C9B1D-7888-4BA8-8EEC-F35ACC2081A6Q33491056-7AD293A5-6CD3-4741-858E-65785FFEDE9BQ33623273-2058472E-DDC6-4B55-819A-6611367D8A3BQ33652840-00EFFACE-9EB1-4081-9E79-3F0B82A130DCQ33698790-EEC82EAB-CAF3-42D2-8E55-6C638738192BQ34003160-6A4FC70C-2621-4DE0-A228-9E0CDB4D860EQ34036608-09601EBF-50A6-47AC-B8EC-31C10437A8D9Q34240555-4CB65D63-4DC3-4F9E-9B30-62B11C7F7A7BQ34269018-1A389E01-F755-4734-9BC2-BC114731BF80Q34300900-42A283B6-9D49-466A-874B-08B1C50B2A06Q34750358-5BDACA06-BE2F-4FBA-9C7B-ACF9AD5D6119Q34876574-4BD313D7-8826-48E1-B124-BA8331091A3BQ34920664-7158BE38-1F64-435E-9D9A-4CA0C838EBC0Q34973958-77C1D1B3-B678-4EFF-B86B-3FC35A3278D7Q35038487-E2BF9E77-3CC5-41BC-B051-DCC08D6F1EABQ35182119-4B892930-2B3E-497F-9449-5FFE2D11EB57Q35215366-5F4C7BD2-3872-4517-B0EB-1AD893451EA6Q35217574-0F4E2D4A-42C5-4E42-B7E4-FF3D0CBF9603Q35534090-54E02748-87C2-4DE1-80B9-2A8763D21274Q35611467-1A333109-6C47-4F11-A12D-39A225A0658AQ35616754-AA5A8F26-0E24-4538-BE92-8FB0FA4C920FQ35746664-E5DD214F-ED36-411F-AE57-762C1671528AQ36116908-C674DB3E-889F-4487-9D14-18775D751A83Q36139885-7C6784E9-15C5-42E5-94D4-E74AA38181EFQ36295461-47D7FFF6-496F-4B3C-A3DD-3BE2E1C5A428Q36394867-9B0D7A6B-C6D6-4F82-888C-4A1C46B677D4Q36536886-BBEDBD3F-DDAA-479F-B488-629355DD6EC2
P2860
Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Downregulation of epithelial a ...... ctor alpha antibody treatment.
@en
Downregulation of epithelial a ...... ctor alpha antibody treatment.
@nl
type
label
Downregulation of epithelial a ...... ctor alpha antibody treatment.
@en
Downregulation of epithelial a ...... ctor alpha antibody treatment.
@nl
prefLabel
Downregulation of epithelial a ...... ctor alpha antibody treatment.
@en
Downregulation of epithelial a ...... ctor alpha antibody treatment.
@nl
P2093
P2860
P356
P1433
P1476
Downregulation of epithelial a ...... ctor alpha antibody treatment.
@en
P2093
P2860
P304
P356
10.1136/GUT.2003.036632
P407
P577
2004-09-01T00:00:00Z